Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-18

Clinical Trial Update: A Non-Inferiority Trial of Stopping Penicillin in Early Rheumatic Heart Disease: GOAL-Stop [Phase 3]

View source ↗

Summary

GOAL-Stop is a Phase 3 non-inferiority trial to determine if stopping penicillin prophylaxis in early rheumatic heart disease is not inferior to continuing it; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Penicillin (prophylaxis) (penicillin)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Rheumatic Heart Disease | Phase 3 | Status: NOT_YET_RECRUITING